Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann, T Raff, T Flohr, N Gökbuget… - Blood, 2006 - ashpublications.org
Adult patients with acute lymphoblastic leukemia (ALL) who are stratified into the standard-
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann, T Raff, T Flohr, N Gökbuget… - …, 2006 - pubmed.ncbi.nlm.nih.gov
Adult patients with acute lymphoblastic leukemia (ALL) who are stratified into the standard-
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
M Brüggemann, T Raff, T Flohr, N Gökbuget, M Nakao… - Blood, 2005 - europepmc.org
Adult patients with acute lymphoblastic leukemia (ALL) who are stratified into the standard-
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
[PDF][PDF] Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann, T Raff, T Flohr, N Gökbuget, M Nakao… - Blood, 2005 - researchgate.net
Investigation of minimal residual disease (MRD) has been proven to be a valuable tool for
predicting outcome in childhood acute lymphoblastic leukemia (ALL). 1-5 In contrast, only a …
predicting outcome in childhood acute lymphoblastic leukemia (ALL). 1-5 In contrast, only a …
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann, T Raff, T Flohr, N Gökbuget… - Blood, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Adult patients with acute lymphoblastic
leukemia (ALL) who are stratified into the standard-risk (SR) group due to the absence of …
leukemia (ALL) who are stratified into the standard-risk (SR) group due to the absence of …
[HTML][HTML] Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann, T Raff, T Flohr, N Gökbuget, M Nakao… - Blood, 2006 - Elsevier
Adult patients with acute lymphoblastic leukemia (ALL) who are stratified into the standard-
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
risk (SR) group due to the absence of adverse prognostic factors relapse in 40% to 55% of …
[引用][C] Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M BRUGGEMANN - Blood, 2006 - cir.nii.ac.jp
Clinical significance of minimal residual disease quantification in adult patients with
standard-risk acute lymphoblastic leukemia | CiNii Research CiNii 国立情報学研究所 学術情報 …
standard-risk acute lymphoblastic leukemia | CiNii Research CiNii 国立情報学研究所 学術情報 …